These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30185806)

  • 1. Machine learning identified an Alzheimer's disease-related FDG-PET pattern which is also expressed in Lewy body dementia and Parkinson's disease dementia.
    Katako A; Shelton P; Goertzen AL; Levin D; Bybel B; Aljuaid M; Yoon HJ; Kang DY; Kim SM; Lee CS; Ko JH
    Sci Rep; 2018 Sep; 8(1):13236. PubMed ID: 30185806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproducible evaluation of classification methods in Alzheimer's disease: Framework and application to MRI and PET data.
    Samper-González J; Burgos N; Bottani S; Fontanella S; Lu P; Marcoux A; Routier A; Guillon J; Bacci M; Wen J; Bertrand A; Bertin H; Habert MO; Durrleman S; Evgeniou T; Colliot O; ;
    Neuroimage; 2018 Dec; 183():504-521. PubMed ID: 30130647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT.
    Chiba Y; Iseki E; Fujishiro H; Ota K; Kasanuki K; Suzuki M; Hirayasu Y; Arai H; Sato K
    Psychiatry Res Neuroimaging; 2016 Mar; 249():105-12. PubMed ID: 26857415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Label-aligned multi-task feature learning for multimodal classification of Alzheimer's disease and mild cognitive impairment.
    Zu C; Jie B; Liu M; Chen S; Shen D; Zhang D;
    Brain Imaging Behav; 2016 Dec; 10(4):1148-1159. PubMed ID: 26572145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial metabolic profiles to discriminate dementia with Lewy bodies from Alzheimer disease.
    Iizuka T; Kameyama M
    J Neurol; 2020 Jul; 267(7):1960-1969. PubMed ID: 32170446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG PET.
    Etminani K; Soliman A; Davidsson A; Chang JR; Martínez-Sanchis B; Byttner S; Camacho V; Bauckneht M; Stegeran R; Ressner M; Agudelo-Cifuentes M; Chincarini A; Brendel M; Rominger A; Bruffaerts R; Vandenberghe R; Kramberger MG; Trost M; Nicastro N; Frisoni GB; Lemstra AW; van Berckel BNM; Pilotto A; Padovani A; Morbelli S; Aarsland D; Nobili F; Garibotto V; Ochoa-Figueroa M
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):563-584. PubMed ID: 34328531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis based SVM classification enables accurate detection of Alzheimer's disease across different clinical centers using FDG-PET and MRI.
    Dukart J; Mueller K; Barthel H; Villringer A; Sabri O; Schroeter ML;
    Psychiatry Res; 2013 Jun; 212(3):230-6. PubMed ID: 23149027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of (18)FDG PET and (11)C-PIB PET brain imaging on the diagnosis of Alzheimer's disease and other dementias in a regional memory clinic in Hong Kong.
    Shea YF; Ha J; Lee SC; Chu LW
    Hong Kong Med J; 2016 Aug; 22(4):327-33. PubMed ID: 27313272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-FDG PET and perfusion SPECT in the diagnosis of Alzheimer and Lewy body dementias.
    O'Brien JT; Firbank MJ; Davison C; Barnett N; Bamford C; Donaldson C; Olsen K; Herholz K; Williams D; Lloyd J
    J Nucl Med; 2014 Dec; 55(12):1959-65. PubMed ID: 25453043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI.
    Massa F; Arnaldi D; De Cesari F; Girtler N; Brugnolo A; Grazzini M; Bauckneht M; Meli R; Morbelli S; Pardini M; Sambuceti G; De Carli F; Tiraboschi P; Nobili F
    Neurobiol Aging; 2019 Apr; 76():9-17. PubMed ID: 30611093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease.
    De Carli F; Nobili F; Pagani M; Bauckneht M; Massa F; Grazzini M; Jonsson C; Peira E; Morbelli S; Arnaldi D;
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):334-347. PubMed ID: 30382303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia.
    Trzepacz PT; Yu P; Sun J; Schuh K; Case M; Witte MM; Hochstetler H; Hake A;
    Neurobiol Aging; 2014 Jan; 35(1):143-51. PubMed ID: 23954175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography.
    Koeppe RA; Gilman S; Junck L; Wernette K; Frey KA
    Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S67-76. PubMed ID: 18632004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic brain pattern in dementia with Lewy bodies: Relationship to Alzheimer's disease topography.
    Perovnik M; Tomše P; Jamšek J; Tang C; Eidelberg D; Trošt M
    Neuroimage Clin; 2022; 35():103080. PubMed ID: 35709556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of Alzheimer's disease from FDG-PET images using favourite class ensembles.
    Cabral C; Silveira M;
    Annu Int Conf IEEE Eng Med Biol Soc; 2013; 2013():2477-80. PubMed ID: 24110229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multilevel Feature Representation of FDG-PET Brain Images for Diagnosing Alzheimer's Disease.
    Pan X; Adel M; Fossati C; Gaidon T; Guedj E
    IEEE J Biomed Health Inform; 2019 Jul; 23(4):1499-1506. PubMed ID: 30028716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Support vector machine-based classification of neuroimages in Alzheimer's disease: direct comparison of FDG-PET, rCBF-SPECT and MRI data acquired from the same individuals.
    Ferreira LK; Rondina JM; Kubo R; Ono CR; Leite CC; Smid J; Bottino C; Nitrini R; Busatto GF; Duran FL; Buchpiguel CA
    Braz J Psychiatry; 2018; 40(2):181-191. PubMed ID: 28977066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular imaging of dementia.
    Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T
    Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syndrome-specific patterns of regional cerebral glucose metabolism in posterior cortical atrophy in comparison to dementia with Lewy bodies and Alzheimer's disease--a [F-18]-FDG pet study.
    Spehl TS; Hellwig S; Amtage F; Weiller C; Bormann T; Weber WA; Hüll M; Meyer PT; Frings L
    J Neuroimaging; 2015; 25(2):281-288. PubMed ID: 24593796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controls-based denoising, a new approach for medical image analysis, improves prediction of conversion to Alzheimer's disease with FDG-PET.
    Blum D; Liepelt-Scarfone I; Berg D; Gasser T; la Fougère C; Reimold M;
    Eur J Nucl Med Mol Imaging; 2019 Oct; 46(11):2370-2379. PubMed ID: 31338550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.